Free Trial

Procaps Group (PROCW) Competitors

$0.02 -0.01 (-35.33%)
As of 02/3/2025

PROCW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Procaps Group stock or one of its competitors? The main competitors of Procaps Group include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Procaps Group vs.

180 Life Sciences (NASDAQ:ATNFW) and Procaps Group (NASDAQ:PROCW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, profitability, risk, earnings, institutional ownership, media sentiment, analyst recommendations and dividends.

In the previous week, 180 Life Sciences had 1 more articles in the media than Procaps Group. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Procaps Group. 180 Life Sciences' average media sentiment score of 1.38 beat Procaps Group's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Positive
Procaps Group Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Procaps Group$414.10MN/AN/AN/AN/A

180 Life Sciences and Procaps Group both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Procaps GroupN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Procaps Group N/A N/A N/A

Summary

180 Life Sciences beats Procaps Group on 2 of the 3 factors compared between the two stocks.

Get Procaps Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PROCW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PROCW vs. The Competition

MetricProcaps GroupDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.35B$5.83B$9.13B
Dividend YieldN/A2.92%4.75%3.85%
P/E RatioN/A4.2726.8119.21
Price / SalesN/A733.09428.3269.68
Price / CashN/A10.2538.0134.83
Price / BookN/A7.507.644.62
Net IncomeN/A$20.70B$3.19B$246.06M
7 Day PerformanceN/A-0.11%-2.13%-2.63%
1 Month PerformanceN/A-0.04%-1.11%-2.57%
1 Year PerformanceN/A97.50%15.71%12.71%

Procaps Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PROCW
Procaps Group
N/A$0.02
-35.3%
N/A-80.6%$0.00$414.10M0.004,900Gap Down
High Trading Volume
ATNFW
180 Life Sciences
N/A$0.01
-6.1%
N/A+4.2%$0.00N/A0.007News Coverage
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AARD
Aardvark Therapeutics
N/A$13.77
+3.5%
N/AN/A$0.00N/A0.0018Insider Trade
News Coverage
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
-7.4%
N/AN/A$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.12
-9.4%
N/A+140.4%$0.00$40,633.000.0040
ALVOW
Alvotech
N/A$2.45
flat
N/A-42.9%$0.00$391.87M0.004Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
-16.9%
N/AN/A$0.00N/A0.004Gap Up
BFRIW
Biofrontera
N/A$0.06
+0.2%
N/A+175.0%$0.00$35.36M0.0070
BTMDW
biote
N/A$0.53
+5.8%
N/AN/A$0.00$193.06M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.13
+11.2%
N/A-93.4%$0.00N/A0.008Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:PROCW) was last updated on 2/23/2025 by MarketBeat.com Staff
From Our Partners